Top Rated Articles

Wedding Invitations Don'ts

By Sarrah Beaumont | 5 Rating | Published 2009-07-21 18:24:23

Much is already written regarding weddin...
Read more..

Car Bodywork Paint Repair Restoration Techniques - Spray Painting

By Mario Goldstein | 5 Rating | Published 2009-07-22 21:11:32

When buying a car one of the biggest cho...
Read more..

How Do I Make My Home Insurance Company Hurry Up?

By Anthony Peck | 5 Rating | Published 2009-08-07 05:45:36

Is there anything more frustrating that ...
Read more..

Do You Really Need Car Insurance

By Warren Fets | 5 Rating | Published 2009-08-21 03:45:27

There are many advantages to having car ...
Read more..

So What Do You Really Know About Fashion?

By Benedict Smythe | 5 Rating | Published 2009-08-24 15:48:39

Fashion is extremely seductive, slightly...
Read more..

Patient Derived Xenograft Models Market | Business Overview By Divya Dsouza

  in Marketing | Published 2019-03-14 05:55:45 | 4 Reads | Unrated

Summary

The global PDX models market is expected to reach to USD 167.6 Million by 2022 from USD 68.0 Million in 2016 at a CAGR of 16.7%.

Full Content

According to a new market research report "Patient Derived Xenograft/PDx Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 167.6 Million by 2022 from an estimated USD 77.4 Million in 2017, at a CAGR of 16.7%.
 

The key factors driving the growth of this market include the growing demand for personalized m

edicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX models is posing a lucrative opportunity in this market.
 

Don’t miss the opportunities in global Patient Derived Xenograft Models Market. Speak to our Analyst for more detailed Information: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121598251
 

By tumor type, the gastrointestinal tumor models segment accounted for the largest share of the market in 2017
 

On the basis of tumor type, the PDx Models Market has been segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models such as head & neck tumors, sarcoma, and melanoma. In 2017, the gastrointestinal tumors segment is expected to account for the largest share of the global PDx Models Market. The respiratory tumors segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this segment is mainly driven by the increasing focus of market players on generating lung cancer PDX models, which could lead to a breakthrough in lung cancer treatment as lung cancer is the leading cause of cancer-related deaths across the globe.
 

Browse and in-depth TOC on "Patient Derived Xenograft Models Market"
 

44 – Tables
34 – Figures
148 – Pages
 

Request Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=121598251
 

By application, the preclinical drug development and basic cancer research held the largest market share in 2017
 

Based on application, the PDx Models Market is further segmented into the preclinical drug development & basic cancer research and biomarker analysis. In 2017, the preclinical drug development and basic cancer research segment is expected to account for the largest share of the global PDx Models Market. The large share of this segment can be mainly attributed to the increasing number of research activities in the field of oncology drug research.
 

North America dominated the market in 2017
 

North America accounted for the largest share of the PDx Models Market in 2017, followed by Europe. The large share of the North American PDx Models Market can be attributed to the growth in biomedical research in the US, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada. However, the Asia Pacific market is projected to grow at the highest CAGR during the forecast period, owing to strong research expenditure and the well-structured CRO industry in China, growth in biomedical & medical research in Japan, rising pharmaceutical R&D expenditure in India, and rising translational and biomedical research in Singapore.
 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121598251
 

The various players in the PDx Models Market include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International, Inc. (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd. (China), Xentech (France), Horizon Discovery Group PLC (UK), Urolead (France), and Explora BioLabs (US).

Comments

Bio Synthesis :Life Science Services at Custom DNA Synthesis
DNA Synthesis
Custom RNA Synthesis
RNA Synthesis
Custom Oligo Synthesis
Cell line authentication
Solid Phase Peptide Synthesis
Cell Line Identification
stapled peptides
Bioconjugation
rna oligo synthesis
long dna synthesis
Amino Acid Analysis
Custom Oligos
Custom Oligo
Oligonucleotide Synthesis
cell line genotyping

Login to comment

About the Author

About OpenArticle

openarticles.com is an article website dealing with the collection of quality articles on a number of subjects including entertainment, arts and science, medicine, career, classifieds, computers, technology, culture, education, entertainment, health, wellness, fitness, diet, writing, world affairs and many more. Read more...

Follow On

Contact: Contact OpenArticles